Formation of CDSCO’s New Intelligence Cell to keep check Illegal Activity In country’s Pharma Sector

To check illegal activities in India’s pharma sector, India’s central drug regulator CDSCO (The Central Drugs Standard Control Organisation) has formed intelligence cell of nine-member. This new cell aims to track illegal activity in the country’s pharmaceutical sector.

According to the officials, the cell has the authority to gather data on the import and export of medicines and cosmetics against the law and investigating complaints related to medicine quality received from overseas regulatory agencies.

This cell will keep tracking and check all the activities carried out in contravention to the provisions of the Drugs & Cosmetics Act, 1940, stated the order and cell will be in charge of collecting and collating information based on that.

The cell also has permissions to assist in raids in collaboration with zonal and sub-zonal offices.

Related Posts

  • Pharma
  • June 24, 2025
  • 91 views
Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…

  • Pharma
  • June 24, 2025
  • 94 views
India’s herbal and ayurvedic OTC market set to outpace global growth

New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India

India’s herbal and ayurvedic OTC market set to outpace global growth

India’s herbal and ayurvedic OTC market set to outpace global growth

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug